The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.

Many cancer patients miss out on advances in diagnosis and treatment. For instance, a significant number of women with BRCA-mutated breast cancer never learn they carry the mutation, says Lionel ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

In a groundbreaking study published in BME Frontiers, researchers from the University of California, Los Angeles (UCLA), in ...

This GEN eBook examines how ddPCR technology is applied in practice through case studies highlighting its analytical strengths over traditional qPCR.

Computational pathology, which assesses molecular-level features of diseases directly from tissue images (rather than testing the tissue via methods such as staining or sequencing) is making rapid ...

Leeron is a New York-based writer who specializes in covering technology for small and mid-sized businesses. Her work has been featured in publications including Bankrate, Quartz, the Village Voice, ...

The firm's Fusion AP digital slide viewing system and AI-based analysis support is now authorized for commercialization in Europe.